Detection of glycopeptide resistance in Staphylococcus aureus

被引：12

作者：

Walsh, TR ^{[1
]}

Howe, RA ^{[1
]}

Wootton, M ^{[1
]}

Bennett, PM ^{[1
]}

MacGowan, AP ^{[1
]}

机构：

[1] Sch Med Sci, Dept Pathol & Microbiol, Bristol, Avon, England

来源：

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY | 2001年 / 47卷 / 03期

关键词：

D O I：

10.1093/jac/47.3.357

中图分类号：

R51 [传染病];

学科分类号：

100401 ;

摘要：

引用

页码：357 / 358

页数：2

共 7 条

[1] Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus [J].

Aucken, HM ;

Warner, M ;

Ganner, M ;

Johnson, AP ;

Richardson, JF ;

Cookson, BD ;

Livermore, DM .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2000, 46 (04) :639-640

[2]

BOLMSTROM A, 1999, 9 EUR C CLIN MICR IN

[3] Methicillin-resistant Staphylococcus aureus clinical strain with reduced vancomycin susceptibility [J].

Hiramatsu, K ;

Hanaki, H ;

Ino, T ;

Yabuta, K ;

Oguri, T ;

Tenover, FC .

JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1997, 40 (01) :135-136

[4] Identification of the up- and down-regulated genes in vancomycin-resistant Staphylococcus aureus strains Mu3 and Mu50 by cDNA differential hybridization method [J].

Kuroda, M ;

Kuwahara-Arai, K ;

Hiramatsu, K .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2000, 269 (02) :485-490

[5] Inactivation of the methicillin resistance gene mecA in vancomycin-resistant Staphylococcus aureus [J].

Sieradzki, K ;

Wu, SW ;

Tomasz, A .

MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1999, 5 (04) :253-257

[6]

WOOTTON M, 2000, IN PRESS J ANTIMICRO

[7]

2000, COMMUNICABLE DIS REP, V10, P99

← 1 →